CMS 2027 Proposed Rule Explained: What the 2.4% Increase Actually Means
Featuring Jay Duty
About This Episode
Transcript
Tom Maxwell (00:16)
All right, welcome to the last visit first podcast studio. Today, my guest, Jay Duty, COO at Maxwell TEC. we're gonna hash through 2027 CMS rule on home health. So CMS just proposed a 2.4% payment increase for home health in 2027. If that's the only number you take away from this, you're missing a lot. So pay attention. Today we are unpacking what is actually happening underneath the headline, a temporary rate cut.
nearly five billion dollar recoupment, a full case mix c recalibration, all landing on the same So this is gonna be Jay and I going back and forth talking about this. So know, every every software vendor, every consulting company, every law group are all putting out articles and press releases and things like that around the the twenty twenty seven proposed rule. And I like to sit down and just chat about it.
make it a lot easier. So if you if you're a listener, if you'd like to read, ⁓ we'll put some documents out you can read. But if you want to hear us and and you want to talk about it, we'll just ⁓ do it through a podcast and we think it'll be better. So Jay, welcome to the show. ⁓ let's get going here. give us the sixty second version of your background and how you ended up focused on home health reimbursement policy. tell us who you are, what you do.
Jay Duty (01:26)
Yeah, actually the first ten years of my career in the hospital business, so I worked for HCA for about ten years and then found my way to post acute care through a an accountable care organization and then moved into to the industry. So I did strategy and there ⁓ in home health and hospice for many years and then was fortunate to find Maxwell and been enjoying working with a team there with you and Jim.
Tom Maxwell (01:47)
That's awesome. All right. Well then when a rule like this drops the first section you turn what's the first section you turn to am I?
Jay Duty (01:53)
Yeah, first I mean, first is the headline numbers, right? You gonna you wanna see what the you typically it's been a cut, right? So the past five years, I noticed kind of the symmetry of it is like it's been it was almost five, almost four, almost three, almost two, almost one, and now it's, you know, not a a permanent adjustment. So that's what we've seen over the last few years. So when I first see it, that's the thing I look for is is what's the damage usually.
Tom Maxwell (01:55)
Course.
sure. Let's break down that what's actually driving it?
Jay Duty (02:21)
Yeah, so the the 2.1% base payment rate update, so to the good, 2.1%. The rest of that 0.3% is in the fixed dollar loss ratio, which kind of clearly stated it's a 0.3% kind of backstop for those high acuity outlier patients. So that's not going to affect too many people, but the headline number of the 2.4% is ⁓ updated. But a big part of that, about $50 million of that, has to do with that.
Fixed dollar loss ratio for those high acuity patients that cost a lot of money to take care of. So not quite everybody's gonna see that same impact for sure.
Tom Maxwell (02:57)
Yeah, we saw a lot more of the outlier payments you know, ten years ago. lot more changes around those. But these are really your, you know, twice a day visits, your B I D diabetics, these patients that require tons and tons of care. So most people don't have a lot of outliers, less than one or two percent. So yeah, that that's kind of a secret number in there. When you roll all together, you say, wow, it's a lot better than you think. But most of those patients don't impact you. So ⁓
Jay Duty (03:17)
Yeah.
Well and and
the big part of that too, again buried in the headline. Again, I look for that headline first, but the three percent, you know, adjustment, temporary adjustment, which is great. And I part of that sixty second version is there is a temporary adjustment of three percent, but there's no permanent adjustment, which I think is is really good for the industry. And again, that trend has been just under five, just under four, three, two, one, so kind of going down a little bit since the the twenty PDGM ⁓ payments coming in. So
good news. You know, but I put a little bit of a question mark behind that because I think there's there's a lot to it when you when you really break down the details.
Tom Maxwell (03:55)
talk a little bit about you were advising a CFO, Maxwell Tech advises a lot of CFOs, what's the one sentence you would want them to remember instead of the two point four four percent figure?
Jay Duty (04:06)
Yeah, I think it's the temporary clawback, right? think for most agencies, that's gonna land somewhere around flat. I would approach it kind of in the in the reverse is you know, engineer the three percent reduction and then kind of start to build back in what's your case mix, what are the LUPA thresholds gonna mean to you as an individual agency. So whether it's like a multi-site, you know, all over, you're gonna have to look at that kind of branch by branch specific to your patient population to understand the impact. So so that's the advice I'd give to a CFO is.
begin with the end in mind. So think about it as a three percent reduction on that temporary adjustment and then build back in what your agency actually looks like.
Tom Maxwell (04:43)
talk about that behavioral adjustment. What explain that? What what did why Why do you think CMS, I mean, you and I both know what's going on here, but what what's what's the real story behind that in your mind?
Jay Duty (04:49)
Yeah.
Yeah,
so in 2020, when we moved to the PDGM model, there was a period of time between about '20 and '22 that they built in, you know, the coding intensity, the visits, LUPAS, all those case mix weights, all those things that matter there. And what they said was, and I think this is kind of the flawed methodology part that the industry's been talking about, they kind of assumed there was going to be this bad behavior, that they needed to adjust for that. That if they put in this model of PDGM,
everybody was going to shift and react to that and and therefore change their behavior. The thing I don't like about that is like it assumes bad intent or bad behavior. The Other thing I think we find ourselves, you know, now we're going into a calendar year 2027 rule that we're living off of old behavioral assumptions there too. And in the meantime, the industry's gotten more efficient, coding's gotten better, there's a lot more tools out there to kind of true-up up the true like regulatory compliance of
and of documentation on the clinical side. So, you know, they're gonna assume this bad behavior, but it didn't assume like what if the industry actually got much, much more tight and better and had better tools to do that. So we're living off, I think, of an old chassis. on this rule too. And so I hate that we're still kind of feeling the effects of too. So they have statutory authority to adjust rates permanently or temporarily as they see fit to to get what they see as like a spending back in line.
there too. So they looked at like what did the industry spend and hey are they going to make all these changes and kind of zig to the zag of what the regulations are too. I just think there's not a of fairness in that ⁓ to just assume people are gonna behave a certain way and punish them for that without it actually happening.
Tom Maxwell (06:26)
Yeah.
Let me give you an example. We we looked at a lot of data under the Mosai Pulse and we started looking at a lot of these ⁓ therapy only cases. And the therapy only cases under this thirty day methodology that CMS proposed back in twenty twenty two around the billing periods. And we see tons of patients get, you know, hip replacement or knee replacement or shoulder repla or you know, shoulder surgery, whatever that the you know, orthopedic surgery is, they get
thirty days worth of visits or they get fifteen visits in the first thirty days, but they discharge and go to outpatient rehab prior to the thirtieth first day. And so the agency thinks they're getting, you know, $3,000, $4,000 for this, you know, super intense care and therapy care that they're doing, but really they're only getting the eighteen hundred dollars or tw or two thousand dollars because they they they didn't get to the second billing period. really caused a lot of pain for a lot of people. And and then we're starting to see this more and more and more where
you know, doctors are putting patients into home health for the first thirty days and then moving them to outpatient therapy and those are really, really expensive episodes. And now you take a haircut on those as well, it really gets expensive. So you may do twelve visits in the first thirty days, really trying to get Nana, you know, back moving or, you know, put up and walking and those kind things. And they discharge her to outpatient rehab and and the home health agency loses money on them. It's pretty wild. so that that clawback is
Four point nine billion dollars is what they said? Explain that. That's crazy.
Jay Duty (07:44)
Yeah.
Yeah, I mean that's the the the temporary adjustment we talked it only affects the rates of the year that it's applied in. So once they're gonna get that back, you know, we've reset that over the years of the permanent adjustments coming in. I think they like this temporary route because it avoids them having to go explain their methodology and and talk about how they're getting that recoupment back with just a large permanent cut.
says there too. So five hundred million of the four point nine billion balance is three percent of that too. So ten percent, right? So based on what the CMS has has said and and what they've described as their approach, it's expected to be looked through temporary adjustments in the future. They should expect the first several years of that to continue to put down your pressure on that. It's not just one time event. So we should we should be looking at that to plan for those
those adjustments coming in the future too. So you're going to take three percent on a temporary adjustment. And again, just because there's a two point one percent raise and then the fixed dollar loss ratio of 0.3, that doesn't mean that all these agencies are going to get there too. So there's a lot of muddy waters that are going to come in there that are going to be agency specific that's going to cause these agencies. I think everybody needs to go look at their individual profile of who are we, what kind of patients are we seeing, how does this really affect us?
Tom Maxwell (09:04)
Yeah, if you're not modeling your data today, you should be. I mean, depending on your EMR and what you use. I there's a couple of EMRs from Current Base I knows one and Well Sky does this as well, others is they out actually load your data as it is today into the new payment amounts and then allow review that data and see where the the impact's gonna have. If the rule comes out as as final as it was proposed, here's the impact it's gonna have to your organization. Are you gonna make money, you gonna lose money where you're at? Don't forget about the wage index. you know, some ⁓
adjustments are going to make around that too. All right, let's jump into this little bit controversial question. So CMS data says or CMS says the data from twenty twenty two forward is too muddled by case mix recalibration and OAC transition to isolate pure PDG and behavioral changes. Do you buy that argument or do you think CMS is just picking data that supports the recruitment it wants to make?
Jay Duty (09:54)
Yeah, I think you could probably this is one of those debate questions that you could probably argue either side of it, right? So, you know, Oasis documentation and recalibration of that, it has merit to say like here's what the here's the care that's been provided and they've got a documented kind of path of that. But we're looking at that from data from twenty to twenty two and we're applying it in twenty twenty seven. So that's that that assumes that there's been no improvement
You know, it d it just it assumes that there's not great defensible reasons clinically for this behavior too. And so if you just it it's gonna muddy it with our our PDGM, you know, clinical groupings and those kind of things. I think LUPA rates also is a very interesting change in this that we'll we'll talk about. but I think there were eighteen different different looper rates that were were shrunk by one visit, which is a lot when you're talking about low utilization, right? One is one is a lot in that in that scenario. So
I think you're gonna have to you're gonna have to document very, very well the care that you provide. And we're gonna have to comment on this too, because again, I think this is where the the industry advocates have been really active and and the the current administration I think is is willing to have the conversation is we're ro we're talking about behavioral adjustments on data from twenty twenty to twenty twenty two that we're making these decisions on now in twenty twenty seven. And it just seems like there's been
enough change and improvement in the organization in the in the industry since
Tom Maxwell (11:18)
Well not that you have all the technology changes and the EMRs are getting better at, you know, capturing the data and making sure that we're answering the questions right and the validations are there. And now we have the new introduction of AI and and Scribe and some people are doing, you know, like companies like Steno and Apricot and those guys are are, you know, using AI and Scribe to to help make sure that the data's documented. And then you got all these companies that are know, the history and physical assessment prior to the start of care to make sure that we're not missing anything in there. So
Why I mean we're we're getting more and more more accurate in the OASIS data set. So why wouldn't you use a more accurate OASIS data set to do your calibration of your numbers? It makes no sense to me. All right. Everybody needs to respond to this in the industry. So ⁓ most people are gonna write comment letters or add their data or feedback into the comment letters and and I highly recommend you do that if you're listening to this and and w we will as well. So Jay will write us a comment letter and we'll we'll lean into the you know, the alliance and you know, some of the of our other bigger friends that are out there that are doing this. But
Jay Duty (11:49)
Yeah, yeah.
Tom Maxwell (12:15)
If you were writing the industry's comment letter in this section, what what would be your strongest counter argument? Like what would you say in there?
Jay Duty (12:21)
Yeah, data, data, data, I think is the the first, second and third ⁓ answer to that. The methodology used to get there, you know, is I think a little bit acuity is a little in there. Like you said, you know, in in all this documentation, you may have a sixteen page document that's coming, you know, at the start of care and you know, somebody didn't go mine every little bit of, yeah, there's this and there's this and yes that does that too. And so I think some of these tools are help highlighting
This is what the patient looks like when they're coming on service there too. There's a lot of rich information in there that, you know, a human that's trying to move fast, trying to get a patient on service and admitted, you know, they're they're not going to be combing through every little detail of that, you know, in real time. And so does that help you get there, get there too? So I think that's one. I think if you look at again, the several old data, the the methodology question, like where where's how is that relevant to the day? And then
You know, what is the adjustment stacked with them the case mix on top of that look like, especially in these rural areas and high cost markets where the wage index is much, much higher, providing that care is much, much higher. You know, what are we what are we weighing whenever we're looking at this kind of in total with all those different factors together? So
Tom Maxwell (13:33)
Yeah. So let's talk about budgeting process. So this rule, first of all, I'll explain it. So the proposed rule comes out right around July fourth, always.
so that happens and then we go into this comment period and then CMS takes all the comments that we give ⁓ they review those comments, they reabut the comments or define the comments or or write write a re response to And the pr final rule comes out, hopefully right around November third is usually when it comes out. I used to think it was a law that they had to give you sixty days to implement, but we found that out last year because the government was shut down. We didn't get sixty days. So somewhere around November third, you're gonna get the rule.
Jay Duty (14:05)
Yeah.
Tom Maxwell (14:11)
Every home health agency that I'm a part of that I've worked has a budget cycle. And that budget cycle starts in September and usually gets finalized around October, ⁓ end of October, it gets sent to the board or to the the leadership teams to approve, and then they they approve their budget for 2027. This rule is going to come out prior to you finishing your or after you finish your budget. So if you're a CFO or you're the finance team at one of these home health agencies.
Talk to us about how you model this so that you can be prepared, so you can create an appropriate budget so you don't miss the budget next year because you didn't have all the data.
Jay Duty (14:46)
Yeah, I think I would do it. I would I would start with again kind of in reverse that, you know, the three percent reduction to get a realistic kind of net rate change before your case mix comes in there. So then you look at your coding distribution, case weight mix, LUPA of thresholds, comorbidities, your clinical groupings, some that'll gain and some that'll lose, and and then look at that blended kind of patient level data. And I I think you can't even do that on
just kind of the average of the average of your especially if you're a multi-site multi-state agency, you can't just look at the averages of all of that. You need to really get a picture of what does it look like in this region? You know, what does it look like with wage adjustments in all those regions and then add in your your 2.1% base update there too because I think you'll get I think a lot in in in large part every year when these come out kind of up or down tends to be relatively flat what the average agency see. So you know really even the
the cut is is still a cut and what we've seen over the few years, especially with the permanent adjustments, and that's what's really driven that. But it tends to be that, you know, a lot of these different clinical groupings, and I think it's kind of intentionally muddy a little bit because they're just looking at the entire Medicare spend on the whole and making those assumptions there and the the patient base as a whole. But you gotta build it around what you're actually what you're actually seeing. So I I don't think it's gonna hit everybody evenly. you got to look at your geography, your patient population.
the payer mix, all those things that are gonna take ⁓ take effect there.
Tom Maxwell (16:16)
Yeah, for sure. And then you also got to remember lot of these agencies historically were eighty, ninety percent Medicare. Now they're, you know, more patients are on Medicare Advantage plans or commercial insurance plans or different kinds of plans. and so now your population's not a hundred percent Medicare. So you gotta so now you're you're creating a budget. You used to create a Medicare budget or a CMS budget, and that was what your budget for your organization. Now you got fifty percent of your population's on Medicare Advantage or a different program. Maybe sixty percent is Medicare.
So forty percent is different. Now you're gonna model that. And then as you create your budget, you gotta figure out how to model are is that gonna flex up or down? Am I gonna take more Medicare advantage, less Medicare advantage? you know, where where where are my referrals coming from? Where are my phone where's my phone ringing at? So I think the budgeting process actually just gets a lot harder with all this stuff.
Jay Duty (16:52)
Yeah.
Tom Maxwell (17:01)
All right, let's talk about visits a little bit. So we're seeing the average visits for thirty day periods, so that PDGM period fall from nearly ten in twenty eighteen to eight in twenty twenty five while we're still having more comorbidity documentation intensity and we're seeing sicker patients. Is this changing because more accuracy or more pressure or what what what do you think's what do you is causing that change?
Jay Duty (17:20)
Yeah.
I think it's I think it's a little bit of both, right? I think it's some of it is we've done a little bit better job in training on documentation on the clinical side for OASIS. The EHRs have driven that documentation and and have improved the capture of those core comorbidities over time. And I think there probably are more complex patients coming home, which is something that we've said as an industry we want to achieve is we want to bring these pay these patients wanna be home. We want to get them there.
it's interesting to me that the visits are declining, the number of visits. That means that there's a lot more going on, a lot more that needs to be documented, and actually less visits. And so that that's think that also a factor that's you know, I can't show you this in the data today, but the pressure on staffing, right? That has to be part of this. It's not just that people have have really streamlined visits. It's you know, we're really trying to find the right staff to get in front of these patients as well as we can. It's not
It's not a supply from a patient standpoint, it's more of a a demand problem of our resources and so ⁓ as an industry. So it's an interesting visit decline. I would love to talk to people in the industry, and I plan to have these conversations, you know, pretty quickly is you know, what are you seeing? Is it are there less visits because you're able to do less visits? You know, there's there's also more restrictions on the payer side of that too, that should be separate and apart from the the Medicare side. So I think we're getting better at documentation. I think we're being asked to do more.
per intense ⁓ documentation, more focus on that specific patient during there instead of just a bunch of subsequent visits. And again, that's a dwindling resource. So getting getting those those nurses, therapists, whatever discipline needs to be in front of those patients timely and regularly is is, you know, continues to be something that's seeing a lot of pressure.
Tom Maxwell (19:07)
Yeah, and I think it's we're really becoming more intentional around the visits, right? So let's really get out there and be intentional with the visit. And technology's helped a ton with that. Like we can check on patients via text message. We can we can, you know, put in ⁓ you know, diff different kind of monitors and those kind of things to monitor patients. And I mean, I think being really intentional about the visits that you're doing. And I mean, if you get the same outcome by doing eight visits versus ten, awesome. But if the outcomes start changing, now we got a problem. All right, let's talk a little bit about on the finance side.
agencies with debt covenants or investor reporting to tied to Medicare growth, what they what should they be doing right now this rule comes final?
Jay Duty (19:45)
I I think that revenue project projections, if you're looking at that again, three percent reduction on your base rate, that's a a downside scenario, at its core. And so you've got to look in and talking to investors before the final rule lands, understanding, hey, you're seeing this headline number of of a two point four percent raise. You know, don't go in there and run your financials and just add two point four percent to it and feel like that's the end of the day. I think you've got to have a sensitivity model that's really driven around.
I know I I sound like a broken record, but your specific patient population, what you're seeing, the the you know, clinical groupings they're in, I would be communicating proactively with them to get an understanding that, you know, hey, let's just not all high five each other and say that we're gonna be, you know, to the good. It it may depend.
Tom Maxwell (20:31)
Yeah, and and you media kind of blew this thing up as ⁓ it's a real positive. Home health's getting a big raise and I know you talked about the multi site, multi state, multi branch. I mean, it's it's crazy when you start really looking at your branches based on the case mix weight, based on the wage index, based on the cuts that are coming, positive or negative. I mean, you can have major swings here. It could be five or six percent up and down, or four or five percent. Remember
The headline was all Medicare patients are getting pay increase. But when you really start diving deep into your locations, there there I've seen some in the past where you know they were getting an eight to ten percent cut just based on know how they how they set the w wage index up. so focus on that, pay attention to that, make sure you're looking at that. let's talk about the parts that everyone else will miss. So CMS is looking ⁓ asking for public input on the home health specific wage index.
Explain what you think that means. Why does it matter? And what good what what would a good outcome actually look like for agencies in high cost labor markets?
Jay Duty (21:28)
Yeah, I don't I think a lot of people probably already realize this, but we're actually built on the the hospital wage index too and not a home health specific one. And so again, that's where we'll ask you to to comment is is the pros and cons of of putting a model out there. If you think about some of the the major disciplines that we really utilize in this space, you know, outside of nurses, therapists, you've got home health aids, LPNs, therapists whose labor markets don't always move in the same way as as some of those RN
wages or therapy wages there too. So it it makes a lot of sense to me that we really need to look at building something directly for home health makes makes a tot a whole lot of sense. in those high cost markets. I mean there's definitely markets that are high cost that also, by the way, have a lot of scrutiny on them right now. And so the intensity of what the what's having to be documented in those settings and you know what that looks like is is that much more ⁓ focused on and is more intense.
And then rural markets. I think that's I think the advocates for the industry, the alliance and others have done a really good job. You know, remember those rural markets where you may be able to list the number of of nurses or therapists or home health aides, you know, on one hand and you know their names and you know that you've gotta go get but it's not th those those resources don't just grow on trees. And there's a lot of patients in those markets need our care. And so those those aren't kind of a one for one resource or supply to demand kind of ratio there too. So
I think it's it's got a lot of merit for us to look at a home health specific wage index.
Tom Maxwell (22:56)
one of the guys I serve on the board with at Tango's his his father was ⁓ looking for home health. He lives in upstate New York, not way upstate, but kinda north of of New York City. Couldn't find a home health provider. He needed one. He paid it. It's it was a Medicare benefit for him, couldn't find a provider. And there was one agency in the in the county, it was a state agency and they couldn't take any more patients and they had a waiting list for like six months and literally he had to go out and f hire a nurse, a human nurse, to be his
Jay Duty (23:05)
Yeah.
Tom Maxwell (23:24)
on on staff for him and just it she was a lady that was at the hospital that would come into his house. He's like, I can't my dad deserves home health. He you know, he's eighty or something years old. He's paid the Medicare benefit, couldn't get anybody to take care of
it was crazy 'cause I he he called me, he's like, Hey, can you help me with I'm like, sure, I'll pull up a I'll you go into Trella Data to figure out everybody New York. Nobody. Nobody could take that county. And they would have to drive like, you know, three hours to get to his dad. Like, well, first of all, you might want to move your dad middle of nowhere, but second of all, there's no there's no healthcare there. So it's pretty wild. Okay, CMS also in this one, and this is what this is headline the parts everyone else will miss, but I don't think everybody's gonna miss this one.
Jay Duty (23:38)
Yeah.
Tom Maxwell (24:00)
But they also expand on their authority to deny, revoke, or or bar ⁓ reapplication for Medicare enrollment, regardless of the reason for denial. So their words in there really mean a lot, regardless of the reason for denial. How much attention is this provision getting relative to the actual risk for providing?
Jay Duty (24:16)
I think it's getting less attention than it deserves. I know we're seeing in the consulting world where you know there's there's whole provider numbers that are completely under scrutiny, building being completely paused. know, I think you're hearing all this about, fraud and you know, I think the industry as at large supports that because nobody wants that. We all feel like we're providing great care there too, there's pretty ⁓ wide ranging, you know, latitude here for CNS CMS to have authority just to
not allow somebody to react reapply and you you're gonna have to be really making sure you're timely on that, that your, you know, there's survey issue, have those survey issues, make sure you've got your plans of action in there. want everybody to be looking at this and not just the finance team. So those with like pass building, licensure survey issues, those kind of things, you're gonna carry this risk that you could really be affected that you could lose your Medicare enrollment. And that ends the business entirely. So
It really is. I mean, I don't think this is, you know, total gloom and doom or, you know, hit the red button, but you really need to be thoughtful about it even when you're reapplying to Medicare too. So the the payment issues get the headlines, but this is there's a lot of scrutiny right now on just provider numbers in general. Obviously there's a moratorium that potentially could be extended through this. And so there's a lot of that, you know, language in here. It feels like that there's a lot of latitude.
Tom Maxwell (25:34)
I totally agree then. Have your lawyer read this one. all the industry advocate lawyers are reading it. This is an area of real scrutiny that we gotta watch out for. All right, let's jump into some ⁓ advocacy stuff. So the the comment period runs through August thirty first of twenty twenty six. Realistically, how the industry comments move a provision like the behavioral adjustment clawback before the final rule is published? everybody's done it for the last twenty plus years and I've been doing this twenty one years now.
see a little bit of action in that, but I mean, do you think if everybody comments we'll get more action or wh where do you think this is headed?
Jay Duty (26:05)
I
think so too. The thing that stands out to me is just how few people comment. I mean there are, you know, there's there's been years, there's calls by everybody to do this and people say, yeah, yeah, yeah, we need to do that, or maybe they do the, you know, the letter that gets generated. I think that's a great tool that, you know, kind of the auto-generated letters to your your congressman and all of that, which is great. But, you know, just thoughtful comments, you know, will go a long way. Data driven, I think is the other thing too. I I I don't think that
it it really happens that they're like, Okay, never mind. we're not gonna do anything like we propose, but we have we have made some headway in in making sure that we we have meaningful influence there too. The size of the cut or the the pace of how quickly those are happening or how much they're s they're pulling pulling in the temporary adjustments or in the permanent adjustment. but yeah, we've got to give well documented data driven pushback to really show the magnitude of what these
these regulations cause to the to the industry writ large.
Tom Maxwell (27:03)
And and I think we've got to be aligned, right? You can't have one person comment in, you know, the sky's blue, the other one says no, it's actually pink, you know, it's right before sunset and those are wrong. Those are different, they're the same but different. But so we need to be super aligned. So I you know, I advise people to reach out to the alliance if you're part of the alliance or whatever other advocacy group you're part of, but make sure we're aligned on these comments and make sure they're and they're kind of all fighting in the same direction or pushing on the right things.
Jay Duty (27:26)
you know, time will tell as as everybody coordinates too, but I mean there's the three percent temporary adjustment. I mean, that seems like a a place that that we should start and show the reasons why that doesn't make sense. the methodology doesn't make sense. The actual care being provided make makes sense. Access to to providers and care, that doesn't make sense there too. We've got to incentivize some of these larger multi state agencies to be in some of these more rural areas providing care because a lot of times to your point about New York.
There's either nobody or a very few amount of providers there that are able to take care of them. So
Tom Maxwell (27:59)
So if I'm an agency executive, if I'm the CEO of a home health agency and I actually want to submit a comment letter versus just complain LinkedIn you know, about how your Medicare's hosing us over, ⁓ what makes a comment letter
valuable for CMS. What wha wha wh wh which ones are gonna really, you know, change the game?
Jay Duty (28:16)
I definitely think the data driven piece too, and I think a lot of times whenever we see the proposed rule, it comes out, you know, around July fourth, which, you know, kind of probably contributes to less people reading it word for word. And then the final one comes out in Halloween. And so it just happens to be that those are those are about the time of year that that the the statutes require to be for those to roll out. So, you know
Tom Maxwell (28:37)
Do you
really think they coordinate that? Do you really think that they they figured that out? They have to, right?
Jay Duty (28:41)
I mean,
it seems like every July 4th weekend, that's that's what happens. Happens to be my birthday weekend. So it always is like, you know, yeah, I could I could read that word for word, but it's a pretty pretty thick document. I know several people that do and I appreciate them for too. But I think if you see that and then you just see those headline numbers and just take to LinkedIn and throw something out and rage against it, that's great. But let's put some real thought into actually sending a comment to CMS, something that's that's data driven, thoughtful.
You said ⁓ said a very good word aligned with the other people that are commenting as well. Let's have a defensible methodology to counter that, not just whining about it two CMS saying, this isn't fair, but have a defensible methodology that you're saying, Well, this is a way that you could objectively look at this and here's what we're actually seeing and here's the data to show you what it looks like when we're actually out here providing care. Here's what it means for us. It's not the headline number of arrays, it's actually tough for us and the wage index, you know, affects us.
doesn't help us enough in some of those in some of those areas. So yeah, I think that's just in instead of raging, just just actually take some time to send a a thoughtful, you know, comment letter, two comment letter to CMS.
Tom Maxwell (29:48)
Sure. All right, zoom out a little bit farther. Five years from now, does this behavioral adjustment true up a mechanism still exist in this form or does something else that structurally changes at CMS?
Jay Duty (29:58)
Yeah, I mean I feel like they've got statutory, they feel like they have statutory authority to do so CMS is gonna I I hope become more thoughtful of that, but in an environment with increased scrutiny, you know, this is kind of a way to do that. And so they're they're kind of thinking through, you way to reduce fraud is to continue to be more stringent on assuming, you know, behavioral models.
that that are not actually based in reality. we've got to coordinate together and talk to them. I I think the behavioral adjustment I think in five years it's impossible to know. I think I think five years is an eternity these days we've we've got to figure out gotta figure out how to sing their song and provide regulatory compliant care that these people really, really need in the home that's documented well.
So that there's, you know, we need to kind of police ourselves so that it's not coming in with this this behavioral adjustment, making sure that we're documenting the acuity of these patients. I think I think patients are are largely, you know, more in need of our services in home health and in hospice than documenting. But in home health especially, I think there's a lot of meat in there in the clinical documentation or the the documentation you get with with orders or face to face from the from prior to the stay that that there's a lot of, you know.
meet in there for those clinical groupings too.
Tom Maxwell (31:20)
Sure, sure. All right. Just another reminder. ⁓ comment period closes August thirty first. If you wanna jump on with us and let us read your comment letter or you want our help write in your comment letter or want to reach out to your software vendor, I'm sure they're all gonna respond or write a letter. So I'm happy to help anybody that wants to do that as well as you know, we'll guide you through the process if you need it. ⁓ last question, if you're an agency owner operator listening to this right now, what should you be doing this week, this quarter, this month? What are you doing right now?
Jay Duty (31:51)
Yeah. ⁓ I think it's not too early to start running your model. I think that if you can if you can run a model today that's driving those comments to say, hey, this is how this would really affect ⁓ affect us, you can get that in before aug August thirty first, at least to you know have some high level modeling to say, here's what it means for us, here's what the headlines say, I think that has a really a a lot a lot more opportunity to influence CMS than than just hey, this isn't
This isn't fair. So yeah, it's not too early to do especially looking at the the clawback and starting there and just seeing what that means and then put your add your case mix to it, clinical group distribution. Don't just throw a national average in there and say this is what my model looks like, but put some thought into it.
Tom Maxwell (32:33)
And I also think people need to start, you know, figuring out how to cut costs, right? Centralization processes, whether it's intake or scheduling or back office, QA, QI, how do we reduce visits if we're gonna have to reduce visits? If Medicare's only gonna pay you this amount of money, you can't spend this amount and be, I mean, no money, no mission. And so you gotta figure out how to start working on all those things. Make your documentation faster, quicker, better. You know, implement, you know, these scribe products that are out there that are that are making nurses happier, figure out how to be more compliant.
Check all the right boxes, it's gonna be super important. All right, Jay. ⁓ if someone wants to reach you, ⁓ how do they get a hold of
Jay Duty (33:08)
easy. Jay at maxwelltech dot com, maxwelltec dot com. We'd love to talk to you about it. I know a lot of people are looking at hey, we've got to optimize what happens in front of the patient, in the back office, through our billing processes, all of those too. So appreciate the time today. And yeah, Jay at Maxwell Tech dot com, love to talk to you.
Tom Maxwell (33:23)
All right. Yeah, or go to www.maxwelltech dot com and just respond there and ⁓ I promise you someone will reach out and talk to you. So appreciate your time today, Jay. Thanks for giving me a good thirty five knowledge and brains and we'll distribute this and we'll do another one of these. we'd also love any comments on these. If we said something wrong or we you want more or you want less, we'd love to we'd love to hear what everybody thinks about you know, instead of doing a document using AI to write this thing up, we just get on here and talk about it. We think it it makes more sense and
It's better for people to listen to it or watch it and ⁓ so appreciate everyone attending, showing and commenting, subscribing. you haven't subscribed to our ⁓ podcast, please do. Thank you.
Jay Duty (33:59)
Thanks.
Thanks for having me.